Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse.
Alcolea D, Pegueroles J, Muñoz L, Camacho V, López-Mora D, Fernández-León A, Le Bastard N, Huyck E, Nadal A, Olmedo V, Sampedro F, Montal V, Vilaplana E, Clarimón J, Blesa R, Fortea J, Lleó A.
Alcolea D, et al.
Ann Clin Transl Neurol. 2019 Sep;6(9):1815-1824. doi: 10.1002/acn3.50873. Epub 2019 Aug 28.
Ann Clin Transl Neurol. 2019.
PMID: 31464088
Free PMC article.
OBJECTIVE: To determine the cutoffs that optimized the agreement between (18) F-Florbetapir positron emission tomography (PET) and Abeta1-42, Abeta1-40, tTau, pTau and their ratios measured in cerebrospinal fluid (CSF) on the LUMIPULSE G600II instrument, we quantified the levels …
OBJECTIVE: To determine the cutoffs that optimized the agreement between (18) F-Florbetapir positron emission tomography (PET) and Abeta1-42 …